Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

[1]  J. Cowan,et al.  Exhaled nitric oxide: a predictor of steroid response. , 2005, American journal of respiratory and critical care medicine.

[2]  J. C. Carranza Rosenzweig,et al.  Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. , 2005, The Journal of pediatrics.

[3]  U. Wahn,et al.  Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study , 2005, Pediatrics.

[4]  Steven Bird,et al.  Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial , 2005 .

[5]  H. Bisgaard,et al.  Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. , 2005, The Journal of allergy and clinical immunology.

[6]  Sean D Sullivan,et al.  Daily versus as-needed corticosteroids for mild persistent asthma. , 2005, The New England journal of medicine.

[7]  A. Fuhlbrigge,et al.  Defining the responder in asthma therapy. , 2005, The Journal of allergy and clinical immunology.

[8]  G. Heldt,et al.  Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.

[9]  P. Montuschi,et al.  Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. , 2004, The Journal of allergy and clinical immunology.

[10]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[11]  L. P. Malmberg.  Exhaled Nitric Oxide in Childhood Asthma—Time to Use Inflammometry Rather Than Spirometry? , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  F. Ducharme.  Inhaled Corticosteroids versus Leukotriene Antagonists as First-Line Therapy for Asthma , 2004, Treatments in respiratory medicine.

[13]  C. Sorkness,et al.  Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. , 2003, The Journal of allergy and clinical immunology.

[14]  M. Klinnert,et al.  Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. , 2003, The Journal of allergy and clinical immunology.

[15]  N. Santanello,et al.  Response to montelukast among subgroups of children aged 2 to 14 years with asthma. , 2003, The Journal of allergy and clinical immunology.

[16]  F. Ducharme.  Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence , 2003, BMJ : British Medical Journal.

[17]  S. Holgate,et al.  Variability and lack of predictive ability of asthma end-points in clinical trials , 2002, European Respiratory Journal.

[18]  M. Goldman,et al.  Within‐ and between‐day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics , 2002, Pediatric pulmonology.

[19]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[20]  P. Kuna,et al.  A randomized, double‐blind trial of the effect of glucocorticoid, antileukotriene and bβ‐agonist treatment on IL‐10 serum levels in children with asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  B. Lipworth,et al.  Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma. , 2002, The Journal of allergy and clinical immunology.

[22]  R. Hancox,et al.  The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. , 2001, American journal of respiratory and critical care medicine.

[23]  E. Baraldi,et al.  Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. , 2001, Respiratory medicine.

[24]  T. Reiss,et al.  Correlation of airway obstruction and patient-reported endpoints in clinical studies. , 2001, The European respiratory journal.

[25]  J. Leff,et al.  Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy , 2001, Current medical research and opinion.

[26]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[27]  B. Lipworth,et al.  Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. , 2000, American journal of respiratory and critical care medicine.

[28]  J. Fahy,et al.  Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. , 2000, The European respiratory journal.

[29]  M. Laviolette,et al.  Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. , 1999, American journal of respiratory and critical care medicine.

[30]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[31]  N. Kissoon,et al.  Exhaled nitric oxide measurements in childhood asthma: Techniques and interpretation , 1999, Pediatric pulmonology.

[32]  H. Bisgaard,et al.  NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. , 1999, American journal of respiratory and critical care medicine.

[33]  Lynn Wei,et al.  Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.

[34]  R. Dockhorn,et al.  Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. , 1998, Archives of internal medicine.

[35]  J. Bernstein,et al.  Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial , 1998 .

[36]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[37]  A. Tattersfield,et al.  Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. , 1991, The American review of respiratory disease.

[38]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.